Aeon Biopharma (AEON) announced the appointment of Rob Bancroft as president and CEO, effective April 29. Bancroft will also join Aeon’s board of directors. Bancroft brings over 25 years of experience in the life sciences industry, spanning biopharmaceuticals, medical devices, and healthcare technology. Prior to joining Aeon he served as GM of the therapeutics business at Revance (RVNC).
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AEON: